Select Medical (SEM) Projected to Announce Earnings on Thursday

Select Medical (NYSE:SEM) will likely be releasing its Q2 2026 results after the market closes on Thursday, July 30th. Analysts expect the company to post earnings of $0.29 per share and revenue of $1.3973 billion for the quarter. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Parties are encouraged to explore the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Friday, August 7, 2026 at 9:00 AM ET.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, April 30th. The health services provider reported $0.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same period in the previous year, the firm earned $0.44 earnings per share. Select Medical’s revenue was up 5.0% on a year-over-year basis. On average, analysts expect Select Medical to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Select Medical Price Performance

Shares of Select Medical stock opened at $16.51 on Tuesday. Select Medical has a 52 week low of $11.65 and a 52 week high of $16.99. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.88. The stock has a market cap of $2.05 billion, a PE ratio of 15.58, a price-to-earnings-growth ratio of 0.95 and a beta of 1.01. The company’s 50-day moving average price is $16.54 and its two-hundred day moving average price is $16.15.

Select Medical Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, May 28th. Investors of record on Thursday, May 14th were issued a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date was Thursday, May 14th. Select Medical’s payout ratio is presently 23.58%.

Institutional Trading of Select Medical

A number of hedge funds have recently bought and sold shares of SEM. Smartleaf Asset Management LLC boosted its holdings in shares of Select Medical by 37.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock worth $43,000 after buying an additional 788 shares during the period. Wilmington Savings Fund Society FSB lifted its position in shares of Select Medical by 20.9% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock valued at $74,000 after acquiring an additional 999 shares in the last quarter. California State Teachers Retirement System lifted its position in shares of Select Medical by 1.4% in the 2nd quarter. California State Teachers Retirement System now owns 102,230 shares of the health services provider’s stock valued at $1,552,000 after acquiring an additional 1,418 shares in the last quarter. Quarry LP acquired a new position in Select Medical in the 4th quarter worth approximately $26,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in Select Medical during the 4th quarter worth approximately $28,000. 89.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on SEM. Mizuho reissued a “neutral” rating and set a $16.50 target price (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. Weiss Ratings raised Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, June 4th. Finally, Zacks Research upgraded Select Medical from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. One equities research analyst has rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $15.50.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.